Evidence map›Paper›PMID 26102509›Full record

ArticlePLoS genetics2015

Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.

Sabine Topka, Joseph Vijai, Michael F Walsh, Lauren Jacobs, Ann Maria, Danylo Villano, Pragna Gaddam, Gang Wu, Rose B McGee, Emily Quinn and 22 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00137111 (Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia), which is not on this map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00137111 phase3completednot on this map

Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

TypeinterventionalSponsorSt. Jude Children's Research HospitalRan2000 to 2014Enrolled501ConditionsLymphoblastic Leukemia, AcuteArmsPrednisone, Dexamethasone, Vincristine, Daunorubicin, Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase, Methotrexate, Cyclophosphamide, Cytarabine, Etoposide, Mercaptopurine, Imatinib, chemotherapy, intrathecal chemotherapy
3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Characterization of Genetic Etiologic Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  3. Article
  4. Importin-9 recognizes the winged-helix fold of ETS transcription factors to mediate nuclear import.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. A germlineScience advances · 2025
    Article
  12. Article
  13. Mycovirus-ContainingInternational journal of molecular sciences · 2024
    Article
  14. Childhood B cell leukemia: Intercepting the paths to progression.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 7 institutions in 3 countries.

Sabine TopkaDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America; Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, New York, United States of America.
Joseph VijaiDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America; Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, New York, United States of America.
Michael F WalshSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Lauren JacobsDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America.
Ann MariaDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America.
Danylo VillanoDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America.
Pragna GaddamDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America.
Gang WuSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Rose B McGeeSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Emily QuinnSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Hiroto InabaSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Christine HartfordSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Ching-Hon PuiSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Alberto PappoSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Michael EdmonsonSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Michael Y ZhangFred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington, United States of America.
Polina StepenskyPediatric Hematology/Oncology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Peter SteinherzDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America.
Kasmintan SchraderUniversity of British Columbia, Vancouver, British Columbia, Canada.
Anne LincolnDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America.
James BusselWeill Cornell Medical College, New York, New York, United States of America.
Steve M LipkinWeill Cornell Medical College, New York, New York, United States of America.
Yehuda GoldgurStructural Biology Program, Sloan Kettering Institute, New York, New York, United States of America.
Mira HaritPediatric Hematology/Oncology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Zsofia K StadlerDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America.
Charles MullighanSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Michael WeintraubPediatric Hematology/Oncology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Akiko ShimamuraFred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington, United States of America; Seattle Children's Hospital, Seattle, Washington, United States of America.
Jinghui ZhangSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
James R DowningSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Kim E NicholsSt Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, United States of America.
Kenneth OffitDepartment of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States of America; Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, New York, United States of America; Weill Cornell Medical College, New York, New York, United States of America.
Memorial Sloan Kettering Cancer Center · USCornell University · USHadassah Medical Center · ILKettering University · USUniversity of Washington · USHebrew University of Jerusalem · ILUniversity of British Columbia · CA

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)R37CA036401 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI EVANS, WILLIAM E · 1987 to 2014
$9.7M
PAARK4Kids-Pharmacogenomics of Anticancer Agents Research in ChildrenU01GM092666 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RELLING, MARY V · 2010 to 2014
$8.9M
Translational Studies of Inherited Marrow Failure and Myelodysplastic SyndromesR24DK099808 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ABKOWITZ, JANIS L, EBERT, BENJAMIN LEVINE · 2013 to 2017
$8.2M
Pharmacogenomics of Childhood Leukemia ALLR01CA036401 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI EVANS, WILLIAM E · 1985 to 2019
$3.6M
Germline Susceptibility in Double Primary Cancers via Nexy-Generation SequencingR21CA178800 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JOSEPH, VIJAI, STADLER, ZSOFIA KINGA · 2014 to 2015
$420k
NCI NIH HHS 5P30 CA08748-40NCI NIH HHS CA178800NCI NIH HHS CA21765NCI NIH HHS CA36401NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA036401NCI NIH HHS R21 CA178800NCI NIH HHS R37 CA036401NIDDK NIH HHS R24 DK099808NIGMS NIH HHS GM92666NIGMS NIH HHS T32 GM007266NIGMS NIH HHS U01 GM092666
6 · The paper itself

Abstract

Somatic mutations affecting ETV6 often occur in acute lymphoblastic leukemia (ALL), the most common childhood malignancy. The genetic factors that predispose to ALL remain poorly understood. Here we identify a novel germline ETV6 p. L349P mutation in a kindred affected by thrombocytopenia and ALL. A second ETV6 p. N385fs mutation was identified in an unrelated kindred characterized by thrombocytopenia, ALL and secondary myelodysplasia/acute myeloid leukemia. Leukemic cells from the proband in the second kindred showed deletion of wild type ETV6 with retention of the ETV6 p. N385fs. Enforced expression of the ETV6 mutants revealed normal transcript and protein levels, but impaired nuclear localization. Accordingly, these mutants exhibited significantly reduced ability to regulate the transcription of ETV6 target genes. Our findings highlight a novel role for ETV6 in leukemia predisposition.

Indexed as

Germ-Line MutationMutation, MissenseAmino Acid SequenceCase-Control StudiesETS Translocation Variant 6 ProteinHeLa CellsHumansMolecular Sequence DataPrecursor Cell Lymphoblastic Leukemia-LymphomaProto-Oncogene Proteins c-etsRepressor ProteinsThrombocytopeniaETS Translocation Variant 6 ProteinProto-Oncogene Proteins c-etsRepressor Proteins

Identifiers

PMID26102509
PMCPMC4477877
OpenAlexW764862773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.